Skip to main content
. 2020 Mar 12;7(4):565–572. doi: 10.1002/acn3.51005

Table 3.

Main clinical features of patients with paroxysmal neurological manifestations (episodic ataxia, paroxysmal dyskinesia) harboring FGF14 mutation previously reported in the literature.

Patient

Choquet

Patient 1

Choquet

Patient 2

Choquet

Patient 3

Amado

Patient 1 & 2

Choi

Coebergh

patient 1

Schesny Shimojima
Chromosomal abnormality/FGF14 gene mutation

NM_004115:c.211_212insA/p.(Ile71Asnfs*27)

Deletion of 424 kb on chromosome 13q33.1 including FGF14 NM_175929:c.31A>/p.(Thr11Ala) Deletion of 202 kb on chromosome 13q33.1 including exons 1‐4 of FGF14

NM_175929:c.208+1G>A

Translocation t(13;21)(q32;q22.3) disrupting FGF14
Sex/age at last follow‐up (years) M/31 M/NK F/NK F/NK M/46 M/6 M/twenties M/6
Acute episodes Episodic ataxia Episodic ataxia Episodic ataxia Episodic ataxia Episodic ataxia Episodic ataxia Episodic ataxia Paroxysmal dyskinesia
Age at onset 26 years NK NK Childhood 39 years Childhood Twenties 8 months
Triggering factor None Fatigue exercise NK Fever NK Fever High emotional stress levels, physical activity, certain body positions (e.g., bending forward), and caffeine intake Crying
Duration NK 20 min NK NK Hours NK Min to hours 5 min
Frequency (or total number) NK 4 times per week Rare NK NK (3 episodes) 4 times per month Several per week
Symptoms Incoor‐dination, unsteady gait, vertical oscillopsy, dysarthria, headache Dysarthria, unsteady gait, and diplopia Vertigo dysatrhia Ataxia Dizziness, headache Ataxia Intense vertigo, dizziness, nausea, dysphagia, diplopia Attacks of choreic movements
Treatment Acetazo‐lamide discontinued due to adverse effects No No No Response to acetazolamide No Improvement after acetazolamide Valproic acid and phenobarbital non effective
Other paroxysmal signs Attacks of right upper limb dystonia No Head‐ache No No No No Breath holding spells from 9 months
Permanent symptoms Yes Yes Yes Yes Yes Yes Yes No
Tremor Yes (From age 29) No No Yes No No UL postural tremor  
Nystagmus Yes (From age 29) Yes Yes Yes Yes Yes Yes  
Ataxia Yes (From age 29) No No Yes No Yes (From age 2) Slight  
Learning difficulties NK NK NK Yes No Yes No Yes (mental al disability)
Psycho‐motor develop‐ment NK NK NK NK Normal Delayed Delayed Mental deficiency

NK, not known; UL, upper limb.